Scottish Brain Sciences works with pharmaceutical, biotech, diagnostics and academic organisations to accelerate the development of new approaches to Alzheimer’s disease and other neurodegenerative conditions.
From participants to data, we bring together expertise, infrastructure and people to support your research at every stage.
Specialist clinical research sites and experienced teams supporting studies from early phase through to large, complex trials.
UKAS ISO 15189 accredited laboratory expertise, including blood and CSF biomarkers, sample testing and biomarker strategy.
Longitudinal clinical, cognitive, biomarker and imaging data through IONA gateway.
We bring together industry, healthcare, academia and the public to revolutionise treatment and management of Alzheimer’s disease and other neurodegenerative conditions.
We partner with pharmaceutical, biotech, diagnostics and academic organisations to support the development of new approaches to neurodegenerative disease research.
Whether you are planning a clinical trial, developing a biomarker strategy or looking for access to longitudinal data, talk to our team about how Scottish Brain Sciences could support you.
